Battelle Secures Sole Award for DTRA STEP 2.0 Contract to Advance Global Biological Threat Reduction Initiatives
Battelle, a global leader in scientific research and national security solutions, has been awarded the Defense Threat Reduction Agency’s (DTRA) Scientific and Technical Engagement Partnership (STEP) 2.0 contract, marking a significant milestone in the field of biological threat reduction (BTR). This award positions Battelle as the sole recipient for this critical program, highlighting its trusted expertise and longstanding contribution to biosurveillance, biosecurity, and threat mitigation initiatives.
The contract carries a base period value of $52.9 million, with the potential to reach a total value of $93.3 million over the full period of performance, reflecting the strategic importance and long-term commitment of the U.S. Department of Defense (DoD) to bolster global biological security frameworks. STEP 2.0 is a continuation and expansion of the U.S. government’s ongoing efforts to address the evolving landscape of biological threats that pose risks to both national security and international stability.
The STEP 2.0 program operates under the Global Threat Reduction (GTR) Directorate of the Defense Threat Reduction Agency. The GTR Directorate’s mission is multifaceted and highly strategic, focusing on preventing the proliferation of Weapons of Mass Destruction (WMDs) and mitigating the impact of emerging biological threats on U.S. military forces, homeland security, and global partners. This includes coordinating international engagements, providing scientific and technical expertise, and building resilience in partner nations’ biological surveillance and response systems.
Through the STEP 2.0 initiative, Battelle is tasked with leading a broad range of Biological Threat Reduction (BTR) efforts that enhance global readiness and security. These efforts include strengthening disease detection and reporting systems, improving the characterization of biological agents, and ensuring rapid response capabilities for potential outbreaks or biological incidents. The contract emphasizes both planned initiatives and the ability to adapt to emerging requirements, demonstrating the dynamic and flexible approach necessary to counter modern biological threats.
“Battelle has a long and proud history of helping nations build resilient biosurveillance and biosecurity systems,” said Dan Pikora, General Manager of Battelle’s National Security Business. “With this new contract, we will expand that mission by partnering with DTRA and global collaborators to strengthen disease detection, characterization, and reporting capabilities that reduce the risk of biological threats before they can cause harm.”
Battelle’s approach to STEP 2.0 leverages its extensive pool of scientific and technical expertise, spanning areas such as epidemiology, molecular biology, infectious disease modeling, bioinformatics, and laboratory diagnostics. By integrating these capabilities, the organization aims to provide a holistic response to biological threats, from early detection and identification to rapid mitigation and prevention. This scientific rigor, combined with operational experience in both domestic and international settings, positions Battelle as a uniquely qualified partner for the U.S. Department of Defense in advancing global biological security objectives.
The STEP 2.0 program builds upon lessons learned from previous iterations of the STEP program, which emphasized international scientific collaboration, capacity building, and technology transfer to enhance partner nations’ ability to detect, report, and respond to biological threats. A key component of STEP 2.0 is the focus on international engagement, fostering cooperation with allied nations and regional partners to address cross-border biological risks that could impact global health security. This collaborative approach not only strengthens U.S. national security but also contributes to global stability by reducing the likelihood of uncontrolled disease outbreaks and biological weapon proliferation.
In practical terms, Battelle’s work under STEP 2.0 will involve a combination of research, technical support, training, and systems integration. This includes establishing and enhancing laboratory capabilities, conducting epidemiological surveillance and analysis, developing and deploying advanced diagnostic tools, and providing expert guidance on biosafety and biosecurity practices. Additionally, the contract emphasizes the importance of agility and innovation, enabling Battelle to respond rapidly to emerging biological threats or unexpected public health events.
The award also reflects Battelle’s longstanding reputation in national security and bioscience. Over the years, the organization has contributed to numerous initiatives aimed at protecting military personnel, first responders, and civilian populations from biological hazards. Its expertise spans the development of biosurveillance networks, pathogen detection systems, threat characterization methods, and global health security programs. The STEP 2.0 contract allows Battelle to further extend these capabilities, integrating cutting-edge scientific methodologies with operational strategies to mitigate biological risks more effectively than ever before.
For the Defense Threat Reduction Agency, the partnership with Battelle under STEP 2.0 represents a strategic investment in preventive measures rather than reactive responses. By strengthening the capabilities of partner nations, improving laboratory and detection infrastructure, and facilitating rapid data sharing, the program seeks to identify and neutralize biological threats at their source, minimizing the likelihood of widespread outbreaks or deliberate misuse.
In addition to the operational and scientific components, STEP 2.0 emphasizes capacity-building and workforce development, ensuring that personnel in partner nations are equipped with the knowledge and skills necessary to sustain biosecurity measures over the long term. Through training programs, workshops, and mentorship, Battelle will help create a cadre of trained professionals capable of maintaining high standards of laboratory safety, epidemiological surveillance, and threat reporting.
Looking ahead, STEP 2.0 is expected to serve as a cornerstone in the global effort to combat biological threats, integrating scientific innovation, international collaboration, and operational readiness. For Battelle, this contract represents both a responsibility and an opportunity: a chance to leverage its extensive expertise in biosciences, national security, and global health to make a tangible difference in protecting both U.S. and allied interests from biological hazards.
In summary, Battelle’s award of the DTRA STEP 2.0 contract underscores the critical importance of scientific and technical engagement in biological threat reduction. Through this partnership, Battelle will play a leading role in enhancing global biosurveillance, improving disease detection and characterization, and strengthening international capacity to respond to biological threats. With a focus on innovation, collaboration, and preparedness, the program aims to mitigate risks before they can escalate, reinforcing both U.S. homeland security and global health resilience.
This initiative marks a significant step forward in the ongoing effort to safeguard nations against emerging biological challenges, demonstrating the vital role of science, expertise, and international cooperation in maintaining a secure and resilient global community.
